breast-cancer-2017-scientifictracks-abstracts

3 / 12

Page 16
Notes:
allied
academies
J Med Oncl Ther 2017 | Volume 2 Issue 3
Breast Cancer November 01-02, 2017 | Toronto, Canada
7th World Congress on
The role of radiologist in conservative management of breast cancer
Tarek Aref
University of Alexandria, Egypt
Breast conserving therapy (BCT) refers to breast conserving
surgery (BCS), followed by moderate-dose radiation
therapy to eradicate any microscopic residual breast disease.
BCS can almost be considered the gold standard of early
stage invasive breast cancer treatment, allowing achieving
the adequate surgical margins with an acceptable cosmetic
outcome. Role of radiologists in breast cancer management
was limited for many years to suggesting an initial diagnosis
and detecting loco-regional recurrence after treatment by
mammogram and breast ultrasonography. The development
of the Breast Imaging Reporting and Data System (BIRADS)
of the American College of Radiology (ACR) helps to change
Radiologist’s role through many factors:, standardized the
description and recommended management of breast
lesions, . BIRADS has increased the radio pathological
correlation of radiologists’ reports, improving the reports’
reliability, and has also established a common language
for all of the physicians involved in multidisciplinary
breast disease management team, favoring agreement on
decisions, and Furthermore, advances in breast magnetic
resonance imaging; functional MRI and image-guided
interventional procedures have increased our responsibility
in the therapeutic decision-making process. The role of
Radiologist in BCT: I is accurate and early diagnosis of breast
cancer and staging II- interventional role of Radiologist in
BCT including imaging-guided biopsy of breast masses,
stereotactic biopsy of non-palpable lesions and or
microcalcifications guided by mammography or MRI. Post-
biopsy-clips insertion and pre-neo adjuvent chemotherapy
localization of malignant lesion by US-guided insertion of
hydromark (clips) preoperative localization of non-palpable
breast mass or micro calcifications by US-guided insertion of
wire and III evaluation of response to neoadjuvant therapy
using RECIST (response evaluation criteria in solid tumors).
Speaker Biography
Tarek Aref is a Professor of Radio Diagnosis and Head of Radio Diagnosis Department,
Medical Research Institute, qualified by Bachelor of Medicine and Surgery (MBCHB),
University of Alexandria, 1985. He did his Master Degree of Radio Diagnosis (MMRD),
University of Alexandria 1990. He is a Doctorate in Radio Diagnosis (MDRD) University
of Alexandria, 1998. He is a Fellowship of the University of Rome (Tor Vergata), Italy
since 1995. He has special work experience: breast imaging and intervention breast
procedures and neuroradiology imaging, training and research: In neuroradiology MRI
at The University of Rome-Italy for 27months between October 1992 and January 1995.
In breast imaging (Digital mammography, MRI and breast intervention techniques) at
the University of Toledo, Ohaio, United States of America, November 2008. He has
Membership of The Egyptian Society of Radiology and Nuclear Medicine, since 1990.
He has Membership of The European Society of Radiology (ECR) since 2002.
e: